Jamie M Bigelow, MD
Pulmonary Disease · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Office
- 1
- Since medical school
- 36 years
- University of Miami, Lm Miller School of Medicine, 1990
Offices
1 location · Hyperbaric Consultants Medical Group Inc · 5 clinicians in this group
Looking this up.
Hospitals listed: UCSF Health Hyde Hospital · UCSF Health Stanyan Hospital. That is not proof they admit you there this week.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bigelow’s office at (415) 345-1246 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence G76533 · Current
Licensed to practise in California · since 1993 · expires 2028-07-31 · University of Miami School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Health Saint Francis HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 2 of 5 · 61% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.251, Oct 2024 – Sep 2025
- UCSF Health St. Mary'S HospitalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for UCSF Health Saint Francis Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.251 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 146 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.41 to 1.26) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 26 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.8 · 52 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.6 · 84 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.2 · 37 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 379 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,255 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,226 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.5 (1.04 to 5.97) · 221 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.37) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (0.52 to 3.89) · 222 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.17 (0 to 16.08) · 111 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.97 (0.74 to 9.21) · 87 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.2 to 3.23) · 55 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.34 (0 to 1.32) · 1,068 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 35 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.499 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 55 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 15.7 · 61 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 54 · 84 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.8 · 100 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.1 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.1 to 18.1) · 87 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.6) · 35 cases | No different | Jan 2024 – Dec 2024 |
What patients said (217 patients answered, 14% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 69% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 68% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 62% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 61% |
| Nurses "always" listened carefully | 67% |
| Nurses "always" treated them with courtesy and respect | 79% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 61% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for UCSF Health St. Mary'S Hospital
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 9 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.99) · 413 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.58 to 1.34) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 146.74 (92.54 to 200.93) · 30 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 51 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 220 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 9.3 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 102 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 1,363 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.02 to 0.46) · 2,530 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.12 to 0.53) · 2,519 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.02 (0.73 to 5.31) · 590 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.35) · 238 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.07 (0.43 to 3.7) · 554 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12.7 (4.19 to 21.21) · 259 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.67 (1.51 to 9.83) · 203 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 168 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 0.99) · 2,258 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 158 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 61 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 291 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.4 · 251 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 5.5 · 189 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.1 · 213 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.7 to 8.5) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12 (8.3 to 17.1) · 30 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.5 · 176 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 61 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.1 (9.6 to 17.8) · 192 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.5) · 113 cases | No different | Jan 2024 – Dec 2024 |
What patients said (587 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$218,620
Medicare paid this office $218,620 for 91 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval | 11 | $176,213 | $201 |
| Management of oxygen chamber therapy | 11 | $19,460 | $91 |
| Return visit (30+ min) | 43 | $7,412 | $118 |
| New patient visit (60+ min) | 27 | $5,522 | $205 |
| Short return visit (20+ min) | 22 | $2,793 | $82 |
See all 7 services
| Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval | 11 | $176,213 | $201 |
| Management of oxygen chamber therapy | 11 | $19,460 | $91 |
| Return visit (30+ min) | 43 | $7,412 | $118 |
| New patient visit (60+ min) | 27 | $5,522 | $205 |
| Short return visit (20+ min) | 22 | $2,793 | $82 |
| New patient visit (45+ min) | 12 | $1,806 | $151 |
| Sleep study including heart rate, breathing, and sleep time | 11 | $1,567 | $142 |
Procedures Medicare counted
| Removal of tissue | 1-10 | None |
Who their Medicare patients are
91 Original Medicare patients in 2024. Average age 75 · Women 40% · Also on Medicaid 23% · Health risk score 1.60. At or below the middle of the specialty; the typical pulmonary disease clinician is at 2.13.
Conditions among them: High blood pressure 73% · Diabetes 29% · Atrial fibrillation 26% · Coronary heart disease 24% · Chronic kidney disease 23% · COPD 23% · Depression 23% · Heart failure 22% · Cancer 15%.
The office billed $1,077,764, Medicare allowed $274,609 and paid $218,620; for 1,305 services of 18 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 91 | 1,305 | 75 | 1.60 | $1,077,764 | $218,620 |
| 2023 | 93 | 1,781 | 75 | 1.58 | $1,500,442 | $279,723 |
| 2022 | 93 | 1,230 | 73 | 1.34 | $964,476 | $187,733 |
| 2021 | 104 | 1,465 | 74 | 1.62 | $1,158,771 | $214,292 |
| 2020 | 89 | 1,893 | 74 | 2.05 | $1,499,081 | $228,523 |
| 2019 | 104 | 998 | 76 | 2.10 | $721,838 | $101,889 |
| 2018 | 129 | 899 | 73 | 2.38 | $615,374 | $83,835 |
| 2017 | 136 | 452 | 73 | 2.29 | $112,355 | $39,967 |
| 2016 | 147 | 522 | 74 | 2.29 | $130,145 | $49,312 |
| 2015 | 180 | 847 | 73 | 2.22 | $181,345 | $87,156 |
| 2014 | 147 | 870 | 73 | 2.12 | $161,135 | $93,532 |
| 2013 | 198 | 1,170 | 73 | 2.01 | $206,370 | $125,372 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval | 14 | $224,163 | $185 |
| Management of oxygen chamber therapy | 14 | $28,030 | $91 |
| Return visit (30+ min) | 60 | $14,627 | $112 |
| New patient visit (60+ min) | 35 | $6,847 | $196 |
| Short return visit (20+ min) | 21 | $2,120 | $73 |
2022: 4 services
| Return visit (30+ min) | 57 | $13,787 | $120 |
| New patient visit (60+ min) | 35 | $6,755 | $193 |
| New patient visit (45+ min) | 17 | $2,622 | $154 |
| Short return visit (20+ min) | 12 | $1,615 | $85 |
2021: 6 services
| Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval | 11 | $160,417 | $176 |
| Management of oxygen chamber therapy | 12 | $21,840 | $94 |
| Return visit (30+ min) | 46 | $8,684 | $119 |
| New patient visit (60+ min) | 28 | $5,702 | $204 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $2,569 | $64 |
| New patient visit (45+ min) | 11 | $1,568 | $143 |
2020: 6 services
| Hyperbaric oxygen under pressure, full body chamber, per 30 minute interval | 17 | $176,589 | $145 |
| Management of oxygen chamber therapy | 17 | $30,258 | $97 |
| Return visit (30+ min) | 45 | $7,804 | $101 |
| New patient visit (60+ min) | 27 | $5,051 | $187 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $2,792 | $65 |
| Short return visit (20+ min) | 18 | $1,447 | $63 |
2019: 4 services
| Return visit (30+ min) | 50 | $7,670 | $97 |
| New patient visit (60+ min) | 29 | $5,266 | $182 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $2,039 | $62 |
| Short return visit (20+ min) | 20 | $1,771 | $68 |
2018: 4 services
| Return visit (30+ min) | 52 | $8,953 | $95 |
| New patient visit (60+ min) | 37 | $6,585 | $178 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $6,526 | $63 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,969 | $175 |
2017: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 62 | $11,481 | $62 |
| Management of oxygen chamber therapy | 12 | $7,902 | $93 |
| Return visit (30+ min) | 36 | $6,370 | $95 |
| New patient visit (60+ min) | 19 | $3,470 | $183 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,606 | $174 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $2,418 | $90 |
2016: 7 services
| Return visit (30+ min) | 49 | $8,839 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 50 | $8,432 | $63 |
| Critical care, first 30-74 minutes | 19 | $5,010 | $193 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $4,838 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $3,603 | $172 |
| New patient visit (60+ min) | 20 | $3,565 | $178 |
| Long return visit (40+ min) | 13 | $2,239 | $132 |
2015: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 50 | $18,523 | $94 |
| Critical care, first 30-74 minutes | 43 | $17,713 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 69 | $13,805 | $65 |
| Return visit (30+ min) | 53 | $9,464 | $98 |
| Management of oxygen chamber therapy | 14 | $8,267 | $97 |
| Critical care, each additional 30 minutes | 28 | $6,314 | $99 |
| New patient visit (60+ min) | 26 | $4,777 | $184 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,461 | $182 |
| Long return visit (40+ min) | 12 | $1,781 | $137 |
2014: 8 services
| Critical care, first 30-74 minutes | 47 | $27,302 | $195 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 41 | $14,864 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 51 | $12,106 | $64 |
| Critical care, each additional 30 minutes | 35 | $10,811 | $97 |
| Management of oxygen chamber therapy | 17 | $10,372 | $107 |
| Return visit (30+ min) | 37 | $7,059 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $3,252 | $181 |
| New patient visit (60+ min) | 15 | $2,822 | $188 |
2013: 9 services
| Critical care, first 30-74 minutes | 72 | $39,965 | $191 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 64 | $23,882 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 72 | $14,094 | $63 |
| Management of oxygen chamber therapy | 19 | $12,205 | $104 |
| Critical care, each additional 30 minutes | 50 | $12,078 | $96 |
| Return visit (30+ min) | 43 | $10,025 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,520 | $176 |
| New patient visit (60+ min) | 17 | $3,147 | $185 |
| Short return visit (20+ min) | 13 | $1,168 | $69 |
Drugs they prescribed that Part D paid
$55,568
Pharmacies billed $55,568 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 176) in 2024. At or below the middle of the specialty; the typical pulmonary disease clinician is at 0%.
83 generic and 93 brand-name prescriptions · $55,568 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trelegy Ellipta | 33 | $19,746 | $598 |
| Breo Ellipta | 17 | $10,671 | $628 |
| Pirfenidone | 14 | $7,036 | $503 |
| Stiolto Respimat | 11 | $5,478 | $498 |
| Fluticasone-Salmeterol | 17 | $2,855 | $168 |
See all 7 drugs
| Trelegy Ellipta | 33 | $19,746 | $598 |
| Breo Ellipta | 17 | $10,671 | $628 |
| Pirfenidone | 14 | $7,036 | $503 |
| Stiolto Respimat | 11 | $5,478 | $498 |
| Fluticasone-Salmeterol | 17 | $2,855 | $168 |
| Wixela Inhub | 27 | $2,766 | $102 |
| Albuterol Sulfate Hfa | 24 | $582 | $24 |
Year by year
| 2024 | 176 | 26 | 0% (0) | 53% | $55,568 |
| 2023 | 142 | 19 | 0% (0) | 57% | $69,296 |
| 2022 | 159 | 35 | 0% (0) | 68% | $240,763 |
| 2021 | 81 | 33 | 0% (0) | 47% | $79,102 |
| 2020 | 141 | 30 | 0% (0) | 57% | $165,796 |
| 2019 | 116 | 34 | 0% (0) | 65% | $180,405 |
| 2018 | 112 | 26 | 0% (0) | 61% | $210,255 |
| 2017 | 111 | 19 | 0% (0) | 46% | $118,644 |
| 2016 | 224 | 39 | 0% (0) | 45% | $114,240 |
| 2015 | 206 | 42 | 0% (0) | 60% | $37,662 |
| 2014 | 172 | 30 | None | 56% | $29,025 |
| 2013 | 237 | 28 | None | 67% | $40,912 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Trelegy Ellipta | 43 | $33,521 | $780 |
| Pirfenidone | 12 | $11,659 | $972 |
| Incruse Ellipta | 11 | $4,202 | $382 |
| Wixela Inhub | 20 | $2,676 | $134 |
| Albuterol Sulfate Hfa | 13 | $621 | $48 |
| Montelukast | 12 | $150 | $12 |
2022: 7 drugs
| Trelegy Ellipta | 26 | $18,758 | $721 |
| Atrovent Hfa | 14 | $6,599 | $471 |
| Spiriva Respimat | 12 | $5,735 | $478 |
| Fluticasone-Salmeterol | 14 | $2,494 | $178 |
| Wixela Inhub | 12 | $1,787 | $149 |
| Albuterol Sulfate Hfa | 20 | $723 | $36 |
| Montelukast | 15 | $137 | $9 |
2021: 1 drug
| Trelegy Ellipta | 13 | $7,282 | $560 |
2020: 3 drugs
| Esbriet | 14 | $137,924 | $9,852 |
| Dexilant | 11 | $3,155 | $287 |
| Omeprazole | 19 | $552 | $29 |
2019: 3 drugs
| Esbriet | 13 | $124,366 | $9,567 |
| Breo Ellipta | 15 | $5,551 | $370 |
| Omeprazole | 19 | $258 | $14 |
2018: 3 drugs
| Esbriet | 12 | $110,639 | $9,220 |
| Advair Diskus | 12 | $4,759 | $397 |
| Flovent Diskus | 11 | $2,718 | $247 |
2017: 3 drugs
| Esbriet | 12 | $103,254 | $8,605 |
| Advair Diskus | 28 | $10,587 | $378 |
| Omeprazole | 21 | $220 | $10 |
2016: 8 drugs
| Advair Diskus | 55 | $19,508 | $355 |
| Spiriva | 12 | $5,830 | $486 |
| Ethambutol | 12 | $1,088 | $91 |
| Omeprazole | 38 | $455 | $12 |
| Rifampin | 12 | $210 | $18 |
| Azithromycin | 12 | $142 | $12 |
| Fluticasone Propionate | 12 | $124 | $10 |
| Pantoprazole | 14 | $103 | $7 |
2015: 7 drugs
| Spiriva | 45 | $16,592 | $369 |
| Advair Diskus | 43 | $16,087 | $374 |
| Proair Hfa | 15 | $766 | $51 |
| Pantoprazole | 18 | $225 | $13 |
| Prednisone | 17 | $152 | $9 |
| Fluticasone Propionate | 13 | $106 | $8 |
| Omeprazole | 11 | $60 | $5 |
2014: 5 drugs
| Advair Diskus | 37 | $14,300 | $386 |
| Spiriva | 18 | $6,944 | $386 |
| Proair Hfa | 15 | $751 | $50 |
| Fluticasone Propionate | 20 | $248 | $12 |
| Prednisone | 16 | $100 | $6 |
2013: 7 drugs
| Advair Diskus | 54 | $18,727 | $347 |
| Spiriva | 38 | $10,476 | $276 |
| Mirapex Er | 12 | $4,649 | $387 |
| Asmanex | 13 | $1,901 | $146 |
| Proair Hfa | 28 | $1,307 | $47 |
| Fluticasone Propionate | 27 | $565 | $21 |
| Pramipexole Dihydrochloride | 14 | $177 | $13 |
Money from drug and device companies
$55 in 2025
| 2025 | 2 | 2 | None | $55 |
| 2024 | 2 | 2 | None | $27 |
| 2021 | 1 | 1 | None | $20 |
| 2019 | 2 | 4 | None | $110 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Solventum | Activ.A.C. | $29 | 1 payment
|
| Molnlycke Health Care US | Mextra Superabsorbant | $26 | 1 payment
|
See all 2 published payments
| Molnlycke Health Care US | Meals · 2025-11-19 | Mextra Superabsorbant | $26 |
| Solventum | Meals · 2025-04-01 | Activ.A.C. | $29 |
See earlier years (2024, 2021, 2019)
2024: $27
| Smith+Nephew | Collagenase Santyl | $16 | 1 payment
|
| Reprise Biomedical | Miro3d | $11 | 1 payment
|
2021: $20
| E.R. Squibb & Sons L.L.C. | Eliquis | $20 | 1 payment
|
2019: $110
| Boehringer Ingelheim Pharmaceuticals | Ofev | $55 | 2 payments
|
| Genentech USA | Esbriet | $55 | 2 payments
|
Professional record
- NPI
- 1043393663
- Licence
- CA G076533, CA G07655California G76533: Current · expires 2028-07-31
- Trained
- University of Miami, Lm Miller School of Medicine, 1990 · 36 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RP1001X (207RP1001X); Federal specialty code 207RC0200X (207RC0200X); Federal specialty code 207RS0012X (207RS0012X); Federal specialty code 2083P0011X (2083P0011X)
- Mailing address
- Po Box 1023, Novato, CA, 94948
- NPI first listed
- 2006-10-24
- NPI last updated
- 2008-10-09
This is when the NPI record was last certified, not a medical board exam.